Plain-English translation of NCT06072768 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing the best way to gradually reduce prednisone—a steroid medication—in people who have rheumatoid arthritis and are currently taking it. The research team wants to find out whether stopping the medication quickly (over 15 days) or slowly (over 150 days) works better and causes fewer problems.
Long-term steroid use can cause side effects, so doctors want to help patients reduce or stop taking these medications. However, stopping too quickly can cause arthritis flare-ups and other health problems. This study will help figure out the safest way to taper the medication.
You likely qualify if…
You likely don't qualify if…
You will be assigned to either a fast tapering schedule (reducing your prednisone over 15 days) or a slow one (over 150 days), depending on your current dose and eligibility. You can participate either in person at a clinic or remotely from home. Throughout the study, your arthritis activity will be measured using either an in-person exam or a questionnaire, and your doctor will monitor how well you tolerate the dose reductions.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
United States